Table 5.

Total direct costs over 12 months for each treatment

Cost (£)	Mirabegron 50 mg	Fesoterodine 4/8 mg	Oxybutynin ER 5 mg	Oxybutynin IR 5 mg	Solifenacin 5/10 mg	Tolterodine ER 4 mg	Tolterodine IR 4 mg	Trospium ER 60 mg	Trospium IR 40 mg	Darifenacin 7.5 mg	Flavoxate 600 mg
All medication	24,744	20,810	11,124	4599	22,634	20,004	4677	17,875	17,907	18,609	9104
First line	22,586	18,022	7969	1145	19,886	17,038	1712	14,827	14,859	15,377	5349
Second line	2158	2788	3155	3455	2748	2965	2965	3047	3047	3232	3755
Co-morbidities	1121	1448	1639	1795	1427	1540	1540	1583	1583	1679	1951
GP visits	5408	5577	5664	5727	5567	5620	5620	5639	5639	5680	5782
Specialist visits	17,674	18,226	18,509	18,715	18,193	18,367	18,367	18,429	18,429	18,565	18,897
Surgical operations	5.19	6.30	6.83	7.18	6.24	6.57	6.57	6.68	6.68	6.93	7.45
Urodynamic tests	4326	5342	5863	6243	5281	5601	5601	5716	5716	5965	6577
Total pad use	17,824	19,076	19,807	20,402	18,996	19,429	19,429	19,592	19,592	19,960	20,999
On treatment	9959	8915	8306	7811	8982	8621	8621	8485	8485	8179	7313
Off treatment	7864	10,161	11,501	12,591	10,014	10,807	10,807	11,107	11,107	11,781	13,687

All doses reported are the total dose per day

ER extended release, GP general practitioner, IR immediate release